149 related articles for article (PubMed ID: 1750193)
1. Nuclear DNA content in 27 pancreatic endocrine tumours: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain.
Donow C; Baisch H; Heitz PU; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1991; 419(6):463-8. PubMed ID: 1750193
[TBL] [Abstract][Full Text] [Related]
2. Malignant potential of aneuploid pancreatic endocrine tumours.
Lee CS; Charlton IG; Williams RA; Dhillon AP; Rode J
J Pathol; 1993 Apr; 169(4):451-6. PubMed ID: 8501543
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients.
Heitz PU; Kasper M; Klöppel G; Polak JM; Vaitukaitis JL
Cancer; 1983 Jan; 51(2):277-82. PubMed ID: 6821817
[TBL] [Abstract][Full Text] [Related]
4. Value of quantitative DNA analysis in endocrine tumors of the pancreas.
Böttger T; Seidl C; Seifert JK; Heintz A; Bretz B; Junginger T
Oncology; 1997; 54(4):318-23. PubMed ID: 9216857
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA ploidy in pancreatic carcinoma.
Linder S; Falkmer U; Hagmar T; Blåsjö M; Sundelin P; von Rosen A
Pancreas; 1994 Nov; 9(6):764-72. PubMed ID: 7846020
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy analysis of mucinous cystic tumors of the pancreas. Correlation of aneuploidy with malignancy and poor prognosis.
Southern JF; Warshaw AL; Lewandrowski KB
Cancer; 1996 Jan; 77(1):58-62. PubMed ID: 8630940
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric determination of DNA content in malignant and benign bone tumours.
Heliö H; Karaharju E; Nordling S
Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material.
Toti P; Greco G; Mangiavacchi P; Bruni A; Palmeri ML; Luzi P
Br J Ophthalmol; 1998 Dec; 82(12):1433-7. PubMed ID: 9930278
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
Hyöty M; Visakorpi T; Kallioniemi OP; Mattila J; Laippala P; Nordback I
Eur J Surg; 1991 Oct; 157(10):595-600. PubMed ID: 1687251
[TBL] [Abstract][Full Text] [Related]
10. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.
Tribukait B; Gustafson H; Esposti PL
Br J Urol; 1982 Apr; 54(2):130-5. PubMed ID: 7082931
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the survival and the clinicopathological parameters of the patients with tumors in the pancreatic head region.
Berczi C; Bocsi J; Lapis K; Balázs G
Acta Chir Hung; 1999; 38(3-4):235-41. PubMed ID: 10935131
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of nuclear DNA content in phaeochromocytoma.
Cope C; Delbridge L; Philips J; Friedlander M
Aust N Z J Surg; 1991 Sep; 61(9):695-8. PubMed ID: 1877940
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
14. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade.
Rugge M; Sonego F; Sessa F; Leandro G; Capella C; Sperti C; Pasquali C; Di Mario F; Pedrazzoli S; Ninfo V
Cancer; 1996 Feb; 77(3):459-66. PubMed ID: 8630952
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of DNA ploidy in gastric cancer.
Yonemura Y; Matsumoto H; Ninomiya I; Ohoyama S; Kimura H; de Aletxabala X; Sugiyama K; Kamata T; Kinoshita K; Fushida S
Anal Cell Pathol; 1992 Mar; 4(2):61-7. PubMed ID: 1550795
[TBL] [Abstract][Full Text] [Related]
16. Nuclear DNA content and clinical follow-up in resected pancreatic adenocarcinoma.
Bui HX; Ballouk F; del Rosario A; Abdulla M; Khan M; Jennings TA; Ross JS
Anal Quant Cytol Histol; 1993 Dec; 15(6):389-95. PubMed ID: 8297429
[TBL] [Abstract][Full Text] [Related]
17. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of nuclear DNA content measurements in pancreatic neoplasms and their Kaplan-Meier survival analysis].
Sun CY; Zhang YL; Chao SL
Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):364-6. PubMed ID: 7842963
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy and S + G2M fraction (proliferative index) as prognostic determinants in human periampullary cancer.
Jorba R; Jaurrieta E; Bernat R; Verdaguer J; Fabregat J; Fernandez-Cruz L
Hepatogastroenterology; 1995; 42(5):740-7. PubMed ID: 8751244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
